MP04-02 5-ALPHA REDUCTASE INHIBITORS AND THE RISK OF PROSTATE CANCER MORTALITY IN MEN TREATED FOR BENIGN PROSTATIC HYPERPLASIA
Author(s) -
Lauren P. Wallner,
Julia DiBello,
Bonnie Li,
Stephen Van Den Eeden,
Sheila Weinmann,
Debra P. Ritzwoller,
Jill E. Abell,
Ralph B. D’Agostino,
Ronald K. Loo,
David S. Aaronson,
Kathryn Richert-Boe,
Ralph I. Horwitz,
Steven J. Jacobsen
Publication year - 2016
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.1937
Subject(s) - medicine , prostate cancer , cancer , 5 alpha reductase inhibitor , hyperplasia , prostate , gerontology , psychoanalysis , finasteride , psychology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom